80
Views
0
CrossRef citations to date
0
Altmetric
Research Article

PEGylated Single-Walled Carbon Nanotubes as Co-Adjuvants Enhance Expression of Maturation Markers in Monocyte-Derived Dendritic Cells

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 171-188 | Received 31 Aug 2020, Accepted 07 Dec 2020, Published online: 09 Feb 2021

References

  • Ben-Valid S , DumortierH, DécossasMet al. Polyaniline-coated single-walled carbon nanotubes: synthesis, characterization and impact on primary immune cells. J. Mater. Chem.20(12), 2408–2417 (2010).
  • Davis VA , Parra-VasquezANG, GreenMJet al. True solutions of single-walled carbon nanotubes for assembly into macroscopic materials. Nat. Nanotechnol.4(12), 830 (2009).
  • Foldvari M , BagonluriM. Carbon nanotubes as functional excipients for nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine4(3), 183–200 (2008).
  • Zeineldin R , Al-HaikM, HudsonLG. Role of polyethylene glycol integrity in specific receptor targeting of carbon nanotubes to cancer cells. Nano Lett.9(2), 751–757 (2009).
  • Kushwaha SKS , GhoshalS, RaiAK, SinghS. Carbon nanotubes as a novel drug delivery system for anticancer therapy: a review. Braz. J. Pharm. Sci.49(4), 629–643 (2013).
  • Balavoine F , SchultzP, RichardC, MallouhV, EbbesenTW, MioskowskiC. Helical crystallization of proteins on carbon nanotubes: a first step towards the development of new biosensors. Angew. Chem. Int. Ed.38(13–14), 1912–1915 (1999).
  • Chen RJ , ZhangY, WangD, DaiH. Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization. J. Am. Chem. Soc.123(16), 3838–3839 (2001).
  • Shao N , WickstromE, PanchapakesanB. Nanotube–antibody biosensor arrays for the detection of circulating breast cancer cells. Nanotechnology19(46), 465101 (2008).
  • Shao N , LuS, WickstromE, PanchapakesanB. Integrated molecular targeting of IGF1R and HER2 surface receptors and destruction of breast cancer cells using single wall carbon nanotubes. Nanotechnology18(31), 315101 (2007).
  • Khosravi F , LoeianSM, PanchapakesanB. Ultrasensitive label-free sensing of IL-6 based on PASE functionalized carbon nanotube micro-arrays with RNA-aptamers as molecular recognition elements. Biosensors7(2), 17 (2017).
  • Kim M-G , ParkJY, ShonY, KimG, ShimG, OhY-K. Nanotechnology and vaccine development. Asain J. Pharm. Sci.9(5), 227–235 (2014).
  • Yan H , XueZ, XieJet al. Toxicity of carbon nanotubes as anti-tumor drug carriers. Int. J. Nanomed.14, 10179 (2019).
  • Kavosi A , NoeiSHG, MadaniSet al. The toxicity and therapeutic effects of single-and multi-wall carbon nanotubes on mice breast cancer. Sci. Rep.8(1), 1–12 (2018).
  • Capek I . Dispersions based on carbon nanotubes–biomolecules conjugates. In: Carbon Nanotubes: Growth and Applications.NaraghiM ( Ed.). IntechOpen, London, UK (2010).
  • Calegari LP , DiasRS, DeOliveira MDet al. Multi-walled carbon nanotubes increase antibody-producing B cells in mice immunized with a tetravalent vaccine candidate for dengue virus. J. Nanobiotechnol.14(1), 61 (2016).
  • Koyama S , EndoM, KimY-Aet al. Role of systemic T-cells and histopathological aspects after subcutaneous implantation of various carbon nanotubes in mice. Carbon44(6), 1079–1092 (2006).
  • Van Panhuis WG , GrefenstetteJ, JungSYet al. Contagious diseases in the United States from 1888 to the present. N. Engl. J. Med.369(22), 2152 (2013).
  • Leleux J , RoyK. Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective. Adv. Healthc. Mater.2(1), 72–94 (2013).
  • Douradinha B , DoolanDL. Harnessing immune responses against Plasmodium for rational vaccine design. Trends Parasitol.27(6), 274–283 (2011).
  • Hogenesch H . Mechanism of immunopotentiation and safety of aluminium adjuvants. Front. Immunol.3, 406 (2013).
  • Chuai X , ChenH, WangWet al. Poly (I: C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting. PLoS One8(1), e54126 (2013).
  • Hogenesch H , O'HaganDT, FoxCB. Optimizing the utilization of aluminium adjuvants in vaccines: you might just get what you want. NPJ Vaccines3(1), 51 (2018).
  • Michel M-L , DengQ, Mancini-BourgineM. Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges. J. Hepatol.54(6), 1286–1296 (2011).
  • van de Laar L , vanden Bosch A, BoonstraAet al. PI3K-PKB hyperactivation augments human plasmacytoid dendritic cell development and function Blood 120(25), 4982–4991 (2012).
  • Sivakumar SM , SukumaranN, NirmalaLet al. Immunopotentiation of hepatitis B vaccine using biodegradable polymers as an adjuvant. J. Microbiol. Immunol. Infect.43(4), 265–270 (2010).
  • Aebig JA , MullenGE, DobrescuGet al. Formulation of vaccines containing CpG oligonucleotides and alum. J. Immunol. Method.323(2), 139–146 (2007).
  • Wu TYH , SinghM, MillerATet al. Rational design of small molecules as vaccine adjuvants. Sci. Transl. Med.6(263), 263ra160 (2014).
  • Scheinberg DA , McDevittMR, DaoT, MulveyJJ, FeinbergE, AlidoriS. Carbon nanotubes as vaccine scaffolds. Adv. Drug Deliv. Rev.65(15), 2016–2022 (2013).
  • Medzhitov R , JanewayCA. Innate immunity: the virtues of a nonclonal system of recognition. Cell91(3), 295–298 (1997).
  • Montomoli E , PiccirellaS, KhadangB, MennittoE, CameriniR, DeRosa A. Current adjuvants and new perspectives in vaccine formulation. Expert Rev. Vaccines10(7), 1053–1061 (2011).
  • Hassan HA , SmythL, RubioNet al. Carbon nanotubes’ surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo. J. Control. Release225, 205–216 (2016).
  • Pescatori M , BedognettiD, VenturelliEet al. Functionalized carbon nanotubes as immunomodulator systems. Biomaterials34(18), 4395–4403 (2013).
  • Ciobotaru C-C , DamianCM, IovuH. Single-wall carbon nanotubes purification and oxidation. UPB Sci. Bull. Ser. B Chem. Mater. Sci.75(2), 55–66 (2013).
  • Suk JS , XuQ, KimN, HanesJ, EnsignLM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev.99, 28–51 (2016).
  • Hadidi N , KobarfardF, Nafissi-VarchehN, AboofazeliR. Optimization of single-walled carbon nanotube solubility by noncovalent PEGylation using experimental design methods. Int. J. Nanomed.6, 737 (2011).
  • Talayev V , TalaevaM, VoroninaE, BabaykinaO. Migration of human dendritic cells in vitro induced by vaccines stimulating humoral and cell immunity. Modern Technol. Med.8(3), 91–99 (2016).
  • Tsai TW , HeckertG, NevesLSFet al. Adsorption of glucose oxidase onto single-walled carbon nanotubes and its application in layer-by-layer biosensors. Anal. Chem.81(19), 7917–7925 (2009).
  • Bozorgmehr M , MoazzeniSM, SalehniaM, SheikhianA, NikooS, ZarnaniA-H. Menstrual blood-derived stromal stem cells inhibit optimal generation and maturation of human monocyte-derived dendritic cells. Immunol. Lett.162(2), 239–246 (2014).
  • De Garibay APR , SpinatoC, KlippsteinRet al. Evaluation of the immunological profile of antibody-functionalized metal-filled single-walled carbon nanocapsules for targeted radiotherapy. Sci. Rep.7(1), 1–12 (2017).
  • Bozzola JJ . Conventional specimen preparation techniques for transmission electron microscopy of cultured cells. Methods Mol. Biol.369, 1–18 (2007).
  • Shakya A , NandakumarK. New generation vaccines: need for safe and improved adjuvants. In: Vaccines and Vaccine Technologies.VasconcelosJR ( Ed.). OMICS Group International, 77–90 (2014).
  • Lycke N , Lebrero-FernándezC. ADP-ribosylating enterotoxins as vaccine adjuvants. Curr. Opin. Pharmacol.41, 42–51 (2018).
  • Ebensen T , DelandreS, ProchnowB, GuzmánCA, SchulzeK. The combination vaccine adjuvant system alum/c-di-AMP results in quantitative and qualitative enhanced immune responses post immunization. Front. Cell. Infect. Microbiol.9, 31 (2019).
  • Hogenesch H , O'HaganDT, FoxCB. Optimizing the utilization of aluminium adjuvants in vaccines: you might just get what you want. NPJ Vaccines3(1), 1–11 (2018).
  • Sivakumar S , SafhiMM, KannadasanM, SukumaranN. Vaccine adjuvants–current status and prospects on controlled release adjuvancity. Saudi Pharm. J.19(4), 197–206 (2011).
  • Didierlaurent AM , MorelS, LockmanLet al. AS04, an aluminium salt-and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol.183(10), 6186–6197 (2009).
  • Fabrizi F , TarantinoA, CastelnovoC, MartinP, MessaP. Recombinant hepatitis B vaccine adjuvanted with AS04 in dialysis patients: a prospective cohort study. Kidney Blood Pressure Res.40(6), 584–592 (2015).
  • Schwarz TF , HuangLM, ValenciaAet al. A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10–14 years. Human Vaccines Immunother.15(7–8), 1970–1979 (2019).
  • Guo Q , ShenXT, LiYY, XuSQ. Carbon nanotubes-based drug delivery to cancer and brain. Curr. Med. Sci.37(5), 635–641 (2017).
  • Ramalingame R , LakshmananA, MüllerF, ThomasU, KanounO. Highly sensitive capacitive pressure sensors for robotic applications based on carbon nanotubes and PDMS polymer nanocomposite. J. Sensors Sensor Syst.8(1), 87–94 (2019).
  • Saliev T . The advances in biomedical applications of carbon nanotubes. C J. Carbon Res.5(2), 29 (2019).
  • Madannejad R , ShoaieN, JahanpeymaF, DarvishiMH, AzimzadehM, JavadiH. Toxicity of carbon-based nanomaterials: reviewing recent reports in medical and biological systems. Chem. Biol. Interact307, 206–222 (2019).
  • Alessandra A , TurcoA, TizianaBet al. Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. 13(12), 6098–6105 (2013).
  • Čolić M , DžopalićT, TomićSet al. Immunomodulatory effects of carbon nanotubes functionalized with a Toll-like receptor 7 agonist on human dendritic cells. Carbon67, 273–287 (2014).
  • Aldinucci A , TurcoA, BiagioliTet al. Carbon nanotube scaffolds instruct human dendritic cells: modulating immune responses by contacts at the nanoscale. Nano Lett.13(12), 6098–6105 (2013).
  • Murakami T , AjimaK, MiyawakiJ, YudasakaM, IijimaS, ShibaK. Drug-loaded carbon nanohorns: adsorption and release of dexamethasone in vitro. Mol. Pharm.1(6), 399–405 (2004).
  • Zhou F , XingD, WuB, WuS, OuZ, ChenWR. New insights of transmembranal mechanism and subcellular localization of noncovalently modified single-walled carbon nanotubes. Nano Lett.10(5), 1677–1681 (2010).
  • Mukherjee SP , BondarenkoO, KohonenPet al. Macrophage sensing of single-walled carbon nanotubes via Toll-like receptors. Sci. Rep.8(1), 1–17 (2018).
  • Smith BR , GhosnEEB, RallapalliHet al. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat. Nanotechnol.9(6), 481 (2014).
  • Orecchioni M , BedognettiD, SgarrellaF, MarincolaFM, BiancoA, DeloguLG. Impact of carbon nanotubes and graphene on immune cells. J. Transl. Med.12(1), 138 (2014).
  • Fadel TR , SteenblockER, SternEet al. Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli. Nano Lett.8(7), 2070–2076 (2008).
  • De Garibay APR , SpinatoC, KlippsteinRet al. Evaluation of the immunological profile of antibody-functionalized metal-filled single-walled carbon nanocapsules for targeted radiotherapy. Sci. Rep.7, 42605 (2017).
  • Tkach AV , ShurinGV, ShurinMRet al. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano5(7), 5755–5762 (2011).
  • Bianco A , HoebekeJ, GodefroySet al. Cationic carbon nanotubes bind to CpG oligodeoxynucleotides and enhance their immunostimulatory properties. J. Am. Chem. Soc.127(1), 58–59 (2005).
  • Gottardi R , DouradinhaB. Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer. J. Nanobiotechnol.11(1), 30 (2013).
  • Yang R , YangX, ZhangZet al. Single-walled carbon nanotubes-mediated in vivo and in vitro delivery of siRNA into antigen-presenting cells. Gene Therapy13(24), 1714 (2006).
  • Gattoardi R , DouradinhaB. Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer. J. Nanobiotechnol.11(30), 1–7 (2013).
  • Zhang C , LiL-H, WangJet al. Enhanced protective immunity against spring viremia of carp virus infection can be induced by recombinant subunit vaccine conjugated to single-walled carbon nanotubes. Vaccine36(42), 6334–6344 (2018).
  • Parra J , Abad-SomovillaA, MercaderJV, TatonTA, Abad-FuentesA. Carbon nanotube-protein carriers enhance size-dependent self-adjuvant antibody response to haptens. J. Control. Release170(2), 242–251 (2013).
  • Meng J , MengJ, DuanJet al. Carbon nanotubes conjugated to tumor lysate protein enhance the efficacy of an antitumor immunotherapy. Small4(9), 1364–1370 (2008).
  • Zeinali M , JammalanM, ArdestaniSK, MosaveriN. Immunological and cytotoxicological characterization of tuberculin purified protein derivative (PPD) conjugated to single-walled carbon nanotubes. Immunol. Lett.126(1–2), 48–53 (2009).
  • Hassan HA , SmythL, WangJT-Wet al. Dual stimulation of antigen presenting cells using carbon nanotube-based vaccine delivery system for cancer immunotherapy. Biomaterials104, 310–322 (2016).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.